Nolla Antimicrobial

Nolla Antimicrobial is pharmaceuticals development company with a proprietary antimicrobial technology, which reduces MRSA and coronavirus (SARS, MERS) >99,99%.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Helsinki, Finland
  • Currency EUR
  • Founded 2013
  • Employees 1
  • Website nollaantimicrobial.com

Company Summary

Business sectors
- Technology license sales to biocide and cosmetics businesses. The Nolla license enables global production of over 30 products, several of which have already been market tested.
- Nolla Polymer sales to licensees.
- Pharmaceutical development. The company has several development projects. The first public program is against Tinea Pedis (athlete's foot).
-Industrial applications of Nolla technology

Team

Previous Investors

  • Sauli Konttila
    Partner
    Unconfirmed
    Mikko Lång
    Partner
    Unconfirmed
    Timo Mäenpää
    Partner
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free